首页> 外文期刊>Microbiology and Immunology >Diagnostic value of serum concentrations of high-mobility group-box protein 1 and soluble hemoglobin scavenger receptor in brucellosis
【24h】

Diagnostic value of serum concentrations of high-mobility group-box protein 1 and soluble hemoglobin scavenger receptor in brucellosis

机译:血清高迁移率基盒蛋白1和可溶性血红蛋白清除剂受体在布鲁氏菌病中的诊断价值

获取原文
获取原文并翻译 | 示例
       

摘要

Both cluster of differentiation (CD)4+ and CD8+ T lymphocytes play key roles in immunity to Brucella, in part because they secrete interferon (IFN)- and activate bactericidal functions in macrophages. Therefore, use of markers of macrophage activation may have diagnostic and prognostic significance. High-mobility group-box 1 protein (HMGB1), a late-onset pro-inflammatory cytokine, is secreted by activated macrophages. Soluble hemoglobin scavenger receptor (sCD163) is a specific marker of anti-inflammatory macrophages. The aim of this study was to investigate the diagnostic value of HMGB1 and sCD163 concentrations in brucellosis and its various clinical forms. Serum HMGB1 and sCD163 concentrations in 49 brucellosis patients were compared with those in 52 healthy control subjects. Both serum HMGB1 and sCD163 concentrations were significantly higher in brucellosis patients than in healthy controls (P<0.001). There were no statistically significant differences in serum concentrations of HMGB1 and sCD163 between cases of acute, subacute and chronic brucellosis. Additionally, serum HMGB1 concentrations were positively correlated with sCD163 concentrations, whereas neither HMGB1 nor sCD163 concentrations were correlated with C-reactive protein concentrations, white cell counts or erythrocyte sedimentation rates. Therefore, serum concentrations of HMGB1 and sCD163 may be diagnostic markers for brucellosis, but neither can be used to differentiate the three different forms of this disease (acute, subacute and chronic).
机译:分化(CD)4+和CD8 + T淋巴细胞簇在对布鲁氏菌的免疫中起关键作用,部分原因是它们分泌干扰素(IFN)-并激活巨噬细胞的杀菌功能。因此,使用巨噬细胞活化标志物可能具有诊断和预后意义。活化的巨噬细胞分泌高迁移率的group-box 1蛋白(HMGB1),它是一种迟发性促炎细胞因子。可溶性血红蛋白清除剂受体(sCD163)是抗炎巨噬细胞的特异性标记。这项研究的目的是调查HMGB1和sCD163浓度在布鲁氏菌病及其各种临床形式中的诊断价值。将49例布鲁氏菌病患者的血清HMGB1和sCD163浓度与52例健康对照者的血清HMGB1和sCD163浓度进行了比较。布鲁氏菌病患者的血清HMGB1和sCD163浓度均显着高于健康对照者(P <0.001)。在急性,亚急性和慢性布鲁氏菌病之间,血清HMGB1和sCD163的浓度无统计学差异。此外,血清HMGB1浓度与sCD163浓度呈正相关,而HMGB1和sCD163浓度均与C反应蛋白浓度,白细胞计数或红细胞沉降率无关。因此,血清HMGB1和sCD163的浓度可能是布鲁氏菌病的诊断标记,但均不能用于区分该疾病的三种不同形式(急性,亚急性和慢性)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号